Betamethasone cream for the treatment of pre-pubertal labial adhesions.

PURPOSE: We evaluated the efficacy of 0.05% betamethasone cream for the treatment of pre-pubertal labial adhesions. METHODS: We retrospectively reviewed the records of 19 children with labial adhesions who were treated with betamethasone cream from 6/2001 to 3/2003. Children were treated with 1 to 3 courses of twice-daily 0.05% betamethasone cream for 4 to 6 weeks. Successful lysis of adhesions was assessed by clinical exam or parental phone contact and outcomes were defined as: (1) success--complete separation of labia, (2) partial success--greater than 75% separation, (3) progression to surgical lysis, and (4) lost to follow-up. RESULTS: Nineteen patients with an average age of 58 months (range 12 to 132 months) were treated. Four of the 19 patients had never been treated previously and 1 had been treated previously with surgical lysis of adhesions only. Fourteen of the 19 patients had been previously treated with conjugated estrogen (Premarin) cream. Two of these fourteen patients had also undergone surgical lysis of adhesions. Severity of adhesions ranged from 33% to 99% labial closure. Betamethasone cream was successful in treating 13/19 (68%) pre-pubertal labial adhesions. Eleven (85%) of these 13 patients had complete resolution of labial adhesions with 1 course of treatment, 1 (7.5%) had resolution with 2 courses of treatment and 1 (7.5%) had resolution with 3 courses of treatment. One patient had a partial success with 3 courses of betamethasone cream. Two (11%) patients underwent surgical lysis of adhesion after 1 and 2 courses of betamethasone cream respectively. Three (16%) patients were lost to follow-up. Average follow-up was 7 months (range 1-24 months). No adverse outcomes or untoward effects were noted in any of the patients treated. CONCLUSIONS: Betamethasone 0.05% cream appears to be a safe and effective treatment of pre-pubertal labial adhesions as primary therapy or in patients that have failed previous therapies and it may avoid the undesirable side effects of breast budding and hyperpigmentation that can be associated with Estrogen creams.

Hyperuricosuric calcium nephrolithiasis.

Since the findings of Yü and Gutman [1], the hyperuricosuric calcium stone former is a unique clinical entity. While an impressive number of clinical and epidemiologic studies implicate hyperuricosuria in calcium stone formation, the exact physicochemical mechanism by which uric acid affects calcium oxalate crystallization has not been proven. Allopurinol decreases stone recurrences and is the drug of choice for patients with isolated HCN.

Is lower pole caliceal anatomy predictive of extracorporeal shock wave lithotripsy success for primary lower pole kidney stones?

PURPOSE: The management of lower pole kidney stones is controversial. We examined whether lower pole caliceal anatomy could predict the success of extracorporeal shock wave lithotripsy of primary lower pole kidney stones 20 mm. or less. MATERIALS AND METHODS: From December 1997 to June 2001, 246 adults with a single, 20 mm. or less radiopaque lower pole renal stone were treated with the Doli 50 lithotriptor (Dornier Medical Systems, Marietta, Georgia) while under general anesthesia. Of the 246 patients 190 (77%) had excretory urography available for review. Lower pole infundibular length and width, lower pole infundibulopelvic angle and caliceal-pelvic height were measurable on 161 (85%), 129 (68%), 128 (67%) and 163 (86%) excretory urograms, respectively. Extracorporeal shock wave lithotripsy was considered a failure if residual stone fragments remained after 1 month, or an auxiliary procedure or re-treatment was required. RESULTS The overall stone-free rate was 78% (32 of 41) for stones 5 mm. or less, 73% (98 of 135) for stones 6 to 10 mm., 43% (22 of 51) for stones 11 to 15 mm. and 30% (7 of 19) for stones 16 to 20 mm. in maximum linear dimension. The stone-free rates grouped according to stone surface area were 76% (48 of 63 stones) for stone surface area 25 mm.2 or less, 69% (97 of 141) for 26 to 100 mm.2 and 33% (14 of 42) for 101 to 400 mm.2. Caliceal anatomy was not predictive of success even with stones grouped as 10 or less or 11 to 20 mm. Grouping patients with favorable (lower pole infundibulopelvic angle 70 degrees or greater, lower pole infundibular length 30 mm. or less and lower pole infundibular width greater than 5 mm.) versus unfavorable (70 degrees or less, greater than 30 mm. and 5 mm. or less, respectively) anatomy was also not predictive of success. CONCLUSIONS: On the Doli 50 machine stone size rather than caliceal anatomy is predictive of treatment outcome. Initial treatment failures with this machine should be managed by alternative endoscopic procedures if necessary rather than by repeat shock wave lithotripsy.